Skip to content
Search

Latest Stories

CCA urges urgent action on shortage of designated prescribing practitioners

CCA urges urgent action on shortage of designated prescribing practitioners

It has repeatedly warned NHS England of the likely consequences arising from the lack of designated prescribing practitioners 

The Company Chemists’ Association (CCA) has raised concern that pharmacies may face challenges in providing placements to pharmacy students graduating in 2025 due to shortages of designated prescribing practitioners (DPPs).


From the academic year 2025/26, all pharmacy students will be required to complete 90 hours of training with designated prescribing practitioners prior to their registration.

However, the CCA has raised doubts regarding the availability of these healthcare professionals to provide such training.

The association said: “We are concerned that pharmacies will be unable to secure DPPs. This will result in a significant reduction in the number of Foundation Pharmacist placements available within the community pharmacy sector.

Consequently, a significant number of graduates leaving university next year will, unfortunately, struggle to find employment in their chosen career.”

As per the CCA, they have repeatedly raised their concerns with NHS England and cautioned them about the potential consequences arising from the lack of DPPs.  

Despite NHSE's repeated assurances that there are sufficient DPPs within the system, pharmacies are reporting difficulties in finding the DPPs, it said.

The CCA has urged NHS England to provide a list of all organisations with available DPPs before releasing placement information to students.

Malcolm Harrison, CEO of the CCA, stated: The CCA has repeatedly warned NHS England about the short supply of Designated Prescribing Practitioners (DPPs).

“NHS England must take control of the situation and provide a full list of all organisations with available DPPs. We want to avoid a situation where our members are unable to offer placements to pharmacy students graduating in 2025.

Malcolm called on NHS England to take swift and decisive action to avert this risk to pharmacy graduate placements.

“Employers do not want to be forced to remove foundation placements from ORIEL, especially considering the existing workforce challenges and exciting opportunities that Independent Prescribing offers,” he noted.

Other trade bodies, such as the National Pharmacy Association (NPA), have echoed serious concerns about this risk to the pharmacist workforce.

From September of 2026 all new qualifying Pharmacists will be Independent Prescribers on the day of registration. To make this possible, several changes have been made to the foundation year including that they must complete 90 hours training with a DPP.

 

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
It is official: Opella is now a standalone company

Opella launches as an independent company to redefine the future of self-care.

Photo credit: gettyimages

Opella becomes standalone company as Sanofi-CD&R deal closes

Opella has officially become a standalone company, following the completion of Sanofi’s sale of a controlling 50.0% stake to private equity firm Clayton, Dubilier & Rice (CD&R).

Sanofi retains a significant shareholding with a 48.2% stake while Bpifrance holds the remaining 1.8% stake.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less